DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)
South Korea flag South Korea · Delayed Price · Currency is KRW
13,940
-210 (-1.48%)
At close: Apr 9, 2026

DAE HWA Pharmaceutical Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
245,233305,315191,632164,306164,657163,255
Market Cap Growth
-14.63%59.32%16.63%-0.21%0.86%-39.51%
Enterprise Value
340,976402,655288,813265,142243,200219,445
Last Close Price
14000.0017430.0010838.569161.159028.018795.54
PE Ratio
148.94184.65360.61-147.5973.63
PS Ratio
1.712.131.281.161.251.39
PB Ratio
3.103.862.512.122.021.96
P/TBV Ratio
5.606.984.493.673.272.96
P/FCF Ratio
94.63117.82218.93--232.62
P/OCF Ratio
45.1856.2536.50-20.1015.72
EV/Sales Ratio
2.382.821.931.881.841.87
EV/EBITDA Ratio
36.1642.7022.0233.8523.4127.08
EV/EBIT Ratio
107.83127.3343.03135.1241.6066.82
EV/FCF Ratio
131.58155.38329.96--312.68
Debt / Equity Ratio
1.221.221.301.431.100.84
Debt / EBITDA Ratio
10.2610.267.5714.118.678.66
Debt / FCF Ratio
37.3537.35113.42--99.96
Net Debt / Equity Ratio
1.151.151.201.251.000.62
Net Debt / EBITDA Ratio
9.629.626.9712.397.906.38
Net Debt / FCF Ratio
34.9934.99104.43-10.64-4.2173.71
Asset Turnover
0.690.690.700.680.700.67
Inventory Turnover
2.892.893.353.864.103.85
Quick Ratio
0.220.220.250.290.330.49
Current Ratio
0.510.510.520.510.620.75
Return on Equity (ROE)
3.00%3.00%1.08%-0.65%1.48%2.31%
Return on Assets (ROA)
0.95%0.95%1.97%0.59%1.94%1.17%
Return on Invested Capital (ROIC)
0.92%0.91%2.15%1.16%1.97%1.04%
Return on Capital Employed (ROCE)
3.50%3.50%7.60%2.20%5.00%3.20%
Earnings Yield
0.67%0.54%0.28%-0.70%0.68%1.36%
FCF Yield
1.06%0.85%0.46%-5.55%-11.84%0.43%
Dividend Yield
1.08%--1.64%1.66%-
Payout Ratio
158.90%158.90%494.43%-235.51%118.28%
Buyback Yield / Dilution
0.70%0.70%-1.13%--0.33%-0.87%
Total Shareholder Return
1.76%0.70%-1.13%1.64%1.34%-0.87%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.